Drugs / BI-CON-02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03062007 | Sep 2016 → Jun 2017 | breast cancer | Biointegrator LLC | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI-CON-02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03062007 ↗ |
| Route | Intravenous | “BI-CON-02 prescribed as intravenous infusion” NCT03062007 ↗ |